For individuals with symptomatic illness demanding therapy, ibrutinib is frequently advised according to 4 stage III randomized clinical trials evaluating ibrutinib with chlorambucil monotherapy106 together with other typically utilized CIT combos, namely FCR, bendamustine moreover rituximab and chl